Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a - PubMed (original) (raw)
. 1976 Nov;117(5 Pt 1):1688-94.
- PMID: 1002996
Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a
H N Fernandez et al. J Immunol. 1976 Nov.
Abstract
Human C5a was isolated from complement-activated serum and was characterized for protein and carbohydrate content. The purified C5a was judged to be homogeneous by both polyacrylamide gel electrophoresis and immunologic techniques. The polypeptide moiety of C5a contains 73 amino acid residues which represent a m.w. of 8,200. Analysis of the carbohydrate moiety in C5a indicated 4 moles of glucosamine, 3 to 4 moles os sialic acid, 4 moles of mannose and 2 moles of galactose. The total carbohydrate content in C5a, therefore, amounts to approximately 25% of the apparent m.w. of the anaphylatoxin molecule. The protein and carbohydrate portions of C5a together equal a m.w. of approximately 11,000 which is considerably less than the 15 to 16,000 indicated by physical measurements. Human C5a contains a COOH-terminal arginine which is essential for anaphylatoxin activity and a sequence of Gln-Leu-Gly-Arg-COOH at the COOH-terminus which compares favorably with that of human C3a (Gly-Leu-Ala-Arg-COOH). Additional similarities between the C3a and C5a molecules include length of the polypeptide chain, number of disulfide bonds and an absence of tryptophan residues. A major chemical difference does exist between these two human anaphylatoxins, namely that carbohydrate is associated with C5a but is absent in the C3a molecule. The partial NH2-terminal sequence of C5a was determined as NH2-Thr-Leu-Glx-Lys-Ile-Glx-Glx-Ile-Ala- and direct comparison with the known sequence of human C3a shows little homology.
Similar articles
- The primary structure of porcine C3a anaphylatoxin.
Corbin NC, Hugli TE. Corbin NC, et al. J Immunol. 1976 Sep;117(3):990-5. J Immunol. 1976. PMID: 956663 - Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP, Hugli TE, Bloor CM. Stimler NP, et al. Am J Pathol. 1980 Aug;100(2):327-48. Am J Pathol. 1980. PMID: 6967702 Free PMC article. - Biochemistry and biology of anaphylatoxins.
Hugli TE. Hugli TE. Complement. 1986;3(3):111-27. doi: 10.1159/000467889. Complement. 1986. PMID: 3542363 Review. - Structure and function of the anaphylatoxins.
Hugli TE. Hugli TE. Springer Semin Immunopathol. 1984;7(2-3):193-219. doi: 10.1007/BF01893020. Springer Semin Immunopathol. 1984. PMID: 6387982 Review.
Cited by
- A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor.
Dézsi L, Mészáros T, Kozma G, H-Velkei M, Oláh CZ, Szabó M, Patkó Z, Fülöp T, Hennies M, Szebeni M, Barta BA, Merkely B, Radovits T, Szebeni J. Dézsi L, et al. Geroscience. 2022 Apr;44(2):597-618. doi: 10.1007/s11357-021-00495-y. Epub 2022 Feb 11. Geroscience. 2022. PMID: 35146583 Free PMC article. - The role of the anaphylatoxins in health and disease.
Klos A, Tenner AJ, Johswich KO, Ager RR, Reis ES, Köhl J. Klos A, et al. Mol Immunol. 2009 Sep;46(14):2753-66. doi: 10.1016/j.molimm.2009.04.027. Epub 2009 May 28. Mol Immunol. 2009. PMID: 19477527 Free PMC article. Review. - Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis.
Tsuruta T, Yamamoto T, Matsubara S, Nagasawa S, Tanase S, Tanaka J, Takagi K, Kambara T. Tsuruta T, et al. Am J Pathol. 1993 Jun;142(6):1848-57. Am J Pathol. 1993. PMID: 8506953 Free PMC article. - Primary structure and functional characterization of rat C5a: an anaphylatoxin with unusually high potency.
Cui L, Carney DF, Hugli TE. Cui L, et al. Protein Sci. 1994 Aug;3(8):1169-77. doi: 10.1002/pro.5560030803. Protein Sci. 1994. PMID: 7987212 Free PMC article. - Comparison of the chemotactic responsiveness of two fibrosarcoma subpopulations of differing malignancy.
Orr FW, Varani J, Delikatny J, Jain N, Ward PA. Orr FW, et al. Am J Pathol. 1981 Feb;102(2):160-7. Am J Pathol. 1981. PMID: 7468766 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources